Volume 66 • 2005 • Number 1

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity

J Clin Psychiatry 2005;66(1):7-14

Brainstorms: Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder? [Free]

J Clin Psychiatry 2005;66(1):5-6

Sertraline Treatment of Pathological Gambling: A Pilot Study

J Clin Psychiatry 2005;66(1):28-33

The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation

J Clin Psychiatry 2005;66(1):15-27

Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

J Clin Psychiatry 2005;66(1):34-40

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

J Clin Psychiatry 2005;66(1):41-48

The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

J Clin Psychiatry 2005;66(1):49-51

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

J Clin Psychiatry 2005;66(1):73-79

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

J Clin Psychiatry 2005;66(1):80-84

A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety

J Clin Psychiatry 2005;66(1):63-72

Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders

J Clin Psychiatry 2005;66(1):52-62

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome." [Free]

J Clin Psychiatry 2005;66(1):134[letter]

What Every Patient, Family, Friend, and Caregiver Needs to Know About Psychiatry, 2nd ed [Free]

J Clin Psychiatry 2005;66(1):139-139 [book review]

Academic Highlights: Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

J Clin Psychiatry 2005;66(1):122-123

Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine

J Clin Psychiatry 2005;66(1):100-106

Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline

J Clin Psychiatry 2005;66(1):94-99

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

J Clin Psychiatry 2005;66(1):107-110

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

J Clin Psychiatry 2005;66(1):85-93

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

J Clin Psychiatry 2005;66(1):111-121

Interactions of Cyclobenzaprine and Tricyclic Antidepressants [Free]

J Clin Psychiatry 2005;66(1):134-135 [letter]

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients [Free]

J Clin Psychiatry 2005;66(1):135-136 [letter]

Problems in Assessing Musical Hallucinations [Free]

J Clin Psychiatry 2005;66(1):135-136 [letter]

Reply to Problems in Assessing Musical Hallucination [Free]

J Clin Psychiatry 2005;66(1):136-136 [letter]

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics. James L. Karagianis and Eduardo Dunayevich [Free]

J Clin Psychiatry 2005;66(1):137-137[letter]

Reply to "Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics." [Free]

J Clin Psychiatry 2005;66(1):138[letter]

Becoming a Therapist: What Do I Say, and Why? [Free]

J Clin Psychiatry 2005;66(1):139-139 [book review]